TTK Healthcare Limited
BSE: TTKHEALTH
Prev Close
1391
Open Price
1393.7
Volume
130
Today Low / High
1380.95 / 1401.65
52 WK Low / High
262.05 / 1401.65
Range
1,321 - 1,460
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 1390.35, reflecting a change of -0.65 (-0.0467%). The expected target range on the BSE is 1,321 - 1,460. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
TTK Healthcare Limited Graph
TTK Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for TTK Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,390.35, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 1,390.35 | 1,404.25 | 1,263.83 - 1,544.68 |
| 1,418.16 | 1,134.53 - 1,701.79 | ||
| 1,432.06 | 1,002.44 - 1,861.68 | ||
| Bearish Scenario | 1,390.35 | 1,376.45 | 1,238.80 - 1,514.09 |
| 1,362.54 | 1,090.03 - 1,635.05 | ||
| 1,348.64 | 944.05 - 1,753.23 |
Overview of TTK Healthcare Limited
ISIN
INE910C01018
Industry
Medical - Devices
Vol.Avg
881
Market Cap
19,646,061,215
Last Dividend
10
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Stock Dividend of TTKHEALTH
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2023-07-18 | July 18, 23 | 10 | 10 | 2023-07-18 | 2023-08-24 | |
| 2022-07-26 | July 26, 22 | 10 | 10 | 2022-07-27 | 2022-08-23 | |
| 2021-08-12 | August 12, 21 | 6 | 6 | 2021-08-14 | 2021-09-07 | |
| 2020-09-03 | September 03, 20 | 3 | 3 | 2020-09-05 | 2020-09-30 | |
| 2019-08-01 | August 01, 19 | 5 | 5 | 2019-08-03 | 2019-08-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 752.79 Cr | 356.00 Cr | 396.79 Cr | 0.5271 | 1.13 Cr | 136.17 Cr | 146.33 Cr | 62.84 Cr | 44.47 | 36.72 Cr | 0.0835 |
| 2023-03-31 | 725.11 Cr | 516.34 Cr | 208.77 Cr | 0.2879 | 1.32 Cr | 85.77 Cr | 19.49 Cr | 639.71 Cr | 452.73 | 32.29 Cr | 0.8822 |
| 2022-03-31 | 599.24 Cr | 424.15 Cr | 175.09 Cr | 0.2922 | 2.93 Cr | 72.12 Cr | 10.34 Cr | 41.59 Cr | 29.43 | 22.92 Cr | 0.0694 |
| 2021-03-31 | 476.06 Cr | 338.01 Cr | 138.05 Cr | 0.2900 | 2.65 Cr | 58.02 Cr | 7.04 Cr | 46.44 Cr | 32.87 | 20.06 Cr | 0.0976 |
| 2020-03-31 | 645.77 Cr | 445.20 Cr | 200.57 Cr | 0.3106 | 4.08 Cr | 91.60 Cr | 15.10 Cr | 12.32 Cr | 8.72 | 29.47 Cr | 0.0191 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 10.96 Cr | 1,200.59 Cr | 199.68 Cr | 1,000.9189 Cr | 22.81 Cr | 11.85 Cr | 96.99 Cr | 75.59 Cr | 0.00 Cr | 0.00 Cr | 35.65 Cr | 195.8164 Cr |
| 2023-03-31 | 9.81 Cr | 1,170.38 Cr | 217.00 Cr | 953.3841 Cr | 27.33 Cr | 17.52 Cr | 89.35 Cr | 79.77 Cr | 0.39 Cr | 1.70 Cr | 14.11 Cr | 210.7799 Cr |
| 2022-03-31 | 15.38 Cr | 559.90 Cr | 230.27 Cr | 329.6314 Cr | 22.21 Cr | 6.83 Cr | 82.71 Cr | 80.48 Cr | 2.17 Cr | 1.89 Cr | 15.13 Cr | 199.0478 Cr |
| 2021-03-31 | 10.25 Cr | 496.41 Cr | 201.77 Cr | 294.6464 Cr | 19.14 Cr | 8.89 Cr | 73.27 Cr | 86.12 Cr | 0.75 Cr | 1.81 Cr | 13.17 Cr | 188.7626 Cr |
| 2020-03-31 | 7.55 Cr | 434.46 Cr | 185.47 Cr | 248.9929 Cr | 29.84 Cr | 22.29 Cr | 74.33 Cr | 97.35 Cr | 0.72 Cr | 1.70 Cr | 8.75 Cr | 171.5047 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | -4.9433 Cr | 28.4935 Cr | -21.9112 Cr | -15.3267 Cr | 1.6390 Cr | 10.9593 Cr | -10.3834 Cr | 62.8419 Cr | -0.5844 Cr | -14.1303 Cr | -12.4752 Cr |
| 2023-03-31 | -2.7072 Cr | 6.9856 Cr | -9.8223 Cr | -14.4063 Cr | -5.5439 Cr | 9.3203 Cr | -11.6991 Cr | 44.6679 Cr | -0.5477 Cr | -14.1303 Cr | 1.9100 Cr |
| 2022-03-31 | 54.9066 Cr | -44.4200 Cr | -5.1772 Cr | 48.4119 Cr | 5.3094 Cr | 14.8642 Cr | -6.4947 Cr | 18.5102 Cr | -0.4602 Cr | -8.4782 Cr | -16.1207 Cr |
| 2021-03-31 | 112.2335 Cr | -95.2752 Cr | -14.9324 Cr | 110.5008 Cr | 2.0259 Cr | 9.5548 Cr | -1.7327 Cr | 36.7817 Cr | -10.6933 Cr | -4.2391 Cr | 1.3409 Cr |
| 2020-03-31 | 24.8741 Cr | -21.6024 Cr | -6.8973 Cr | 12.6394 Cr | -3.6256 Cr | 7.5289 Cr | -12.2347 Cr | 12.3194 Cr | 1.6201 Cr | -8.5174 Cr | -16.3357 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 207.90 Cr | 93.53 Cr | 114.37 Cr | 0.5501 | 76.01 Cr | 31.58 Cr | 22.35 | 7.93 Cr | 0.1519 |
| 2024-03-31 | 181.06 Cr | 101.73 Cr | 79.32 Cr | 0.4381 | -70.55 Cr | 18.27 Cr | 12.93 | 12.33 Cr | 0.1009 |
| 2023-12-31 | 183.85 Cr | 121.20 Cr | 62.65 Cr | 0.3408 | 2.03 Cr | 12.89 Cr | 9.13 | 5.33 Cr | 0.0701 |
| 2023-09-30 | 185.77 Cr | 120.74 Cr | 65.03 Cr | 0.3500 | 6.26 Cr | 16.01 Cr | 11.33 | 9.53 Cr | 0.0862 |
| 2023-06-30 | 202.12 Cr | 122.67 Cr | 79.46 Cr | 0.3931 | 6.89 Cr | 15.67 Cr | 11.09 | 10.04 Cr | 0.0775 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 845.21 Cr | 0.00 Cr | 0.00 Cr | 845.21 Cr | 0.00 Cr | 0.00 Cr | -1,000.92 Cr |
| 2024-03-31 | 10.96 Cr | 834.25 Cr | 845.21 Cr | 86.44 Cr | 96.99 Cr | 1,077.30 Cr | 75.59 Cr | 1,200.59 Cr | 199.68 Cr |
| 2023-12-31 | -844.96 Cr | 1,689.93 Cr | 844.96 Cr | 0.00 Cr | 0.00 Cr | 844.96 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 844.96 Cr | 869.64 Cr | 844.96 Cr | 92.35 Cr | 89.52 Cr | 1,076.96 Cr | 78.20 Cr | 1,182.28 Cr | 209.92 Cr |
| 2023-06-30 | -846.67 Cr | 1,693.34 Cr | 846.67 Cr | 0.00 Cr | 0.00 Cr | 846.67 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 31.58 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 18.27 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 12.89 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 16.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-06-30 | 15.67 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Devices
No stocks found in this industry.
Key Executives
No executive data available.
FAQs about TTK Healthcare Limited
The current price is ₹1,390.35.
The range is ₹262.05-1401.65.
The market capitalization is ₹1,964.61 crores.
The P/E ratio is 39.41.
The company operates in the Healthcare sector.
Overview of TTK Healthcare Limited (ISIN: INE910C01018) is a leading Medical - Devices in India. With a market capitalization of ₹1,964.61 crores and an average daily volume of 881 shares, it operates in the Medical - Devices. The company last declared a dividend of ₹10.